Financials data is unavailable for this security.
View more
Year on year Seed Co Ltd grew revenues 5.89% from 30.59bn to 32.40bn while net income improved from a loss of 316.09m to a gain of 1.96bn.
| Gross margin | 43.13% |
|---|---|
| Net profit margin | 5.18% |
| Operating margin | 4.74% |
| Return on assets | 3.65% |
|---|---|
| Return on equity | 11.22% |
| Return on investment | 6.06% |
More ▼
Cash flow in JPYView more
In 2024, Seed Co Ltd increased its cash reserves by 99.50%, or 4.91bn. The company earned 6.02bn from its operations for a Cash Flow Margin of 18.59%. In addition the company generated 2.64bn cash from financing while 3.76bn was spent on investing.
| Cash flow per share | 175.01 |
|---|---|
| Price/Cash flow per share | 2.92 |
| Book value per share | 580.10 |
|---|---|
| Tangible book value per share | 547.77 |
More ▼
Balance sheet in JPYView more
| Current ratio | 1.16 |
|---|---|
| Quick ratio | 0.7949 |
| Total debt/total equity | 1.50 |
|---|---|
| Total debt/total capital | 0.5962 |
More ▼
Growth rates in JPY
Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 25.00% and 712.99%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Medical Equipment & Supplies industry pay a dividend. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked in-line with the industry average relative to its peers.
| Div yield(5 year avg) | 1.89% |
|---|---|
| Div growth rate (5 year) | 4.56% |
| Payout ratio (TTM) | 26.93% |
| EPS growth(5 years) | 14.99 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | 312.03 |
More ▼
